Gene · 6300
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis. | Sci Rep | 2022 | 35304529 | PubTator, text mining | PubMed |
| Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations. | Clin Cancer Res | 2022 | 35294533 | PubTator, text mining | PubMed |
| Functional characterization of the human Cdk10/Cyclin Q complex. | Open Biol | 2022 | 35291876 | PubTator, text mining | PubMed |
| Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research. | Immune Netw | 2022 | 35291656 | PubTator, text mining | PubMed |
| TMBIM1 promotes proliferation and attenuates apoptosis in glioblastoma cells by targeting the p38 MAPK signalling pathway. | Transl Oncol | 2022 | 35279540 | PubTator, text mining | PubMed |
| Metformin Intervention-A Panacea for Cancer Treatment? | Cancers (Basel) | 2022 | 35267644 | PubTator, text mining | PubMed |
| Phosphoproteomic analysis of thrombin- and p38 MAPK-regulated signaling networks in endothelial cells. | J Biol Chem | 2022 | 35257745 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma. | Cell Death Dis | 2022 | 35246508 | PubTator, text mining | PubMed |
| The future of inhalation therapy in chronic obstructive pulmonary disease. | Curr Res Pharmacol Drug Discov | 2022 | 35243334 | PubTator, text mining | PubMed |
| Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma. | Front Cell Dev Biol | 2022 | 35237602 | PubTator, text mining | PubMed |
| Xanthohumol targets the JNK1/2 signaling pathway in apoptosis of human nasopharyngeal carcinoma cells. | Environ Toxicol | 2022 | 35229981 | PubTator, text mining | PubMed |
| Identification of novel regulators required for early development of vein pattern in the cotyledons by single-cell RNA-sequencing. | Plant J | 2022 | 35218590 | PubTator, text mining | PubMed |
| Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation. | J Biol Chem | 2022 | 35216969 | PubTator, text mining | PubMed |
| Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms. | Pharmaceutics | 2022 | 35214064 | PubTator, text mining | PubMed |
| Interplay between nuclear factor-κB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells. | J Biol Chem | 2022 | 35189144 | PubTator, text mining | PubMed |
| A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4. | Stem Cell Reports | 2022 | 35180397 | PubTator, text mining | PubMed |
| Theranostic Interpolation of Genomic Instability in Breast Cancer. | Int J Mol Sci | 2022 | 35163783 | PubTator, text mining | PubMed |
| Kinome-Wide Profiling Identifies Human WNK3 as a Target of Cajanin Stilbene Acid from Cajanus cajan (L.) Millsp. | Int J Mol Sci | 2022 | 35163434 | PubTator, text mining | PubMed |
| Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma. | Int J Mol Sci | 2022 | 35163030 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6300/papers?page=20